Danaher Corporation vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
7.7
Bullish
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
DHR
Clean balance sheet with low leverage (0.4× debt-to-equity).
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $250.14 (+42.8%)
22 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
DHR
UNH
33.9×
Trailing P/E
27.9×
19.3×
Forward P/E
17.8×
14.9%
Profit Margin
2.7%
59.0%
Gross Margin
18.8%
7.1%
ROE
12.2%
3.7%
Revenue Growth
2.0%
9.8%
Earnings Growth
0.7%
0.99
Beta
0.41
—
Price / Book
—
$124.0B
Market Cap
$334.9B
$175 – $243
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →